{"meta":{"query_hash":"ca8eed8d22fc","filters":{"venue":"Human Gene Therapy Clinical Development"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ca8eed8d22fc","api":"https://metacan.xera.ac/api/v1/cohort?venue=Human+Gene+Therapy+Clinical+Development"},"results":[{"id":"W1920785403","doi":"10.1089/humc.2014.145","title":"A Multicenter, Single-Blind, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of a Cell-Mediated Gene Therapy in Degenerative Knee Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoarthritis; WOMAC; Medicine; Cartilage; Adverse effect; Visual analogue scale; Clinical endpoint; Internal medicine; Randomized controlled trial; Arthritis; Surgery; Pathology","score_opus":0.19683239178574596,"score_gpt":0.416537915641443,"score_spread":0.21970552385569703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920785403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853286,0.003224725,0.0008743627,0.0006031964,0.000479893,0.0062847342,0.00077510654,0.0001164909,0.002312834],"genre_scores_gemma":[0.9739189,0.0025798145,0.0028244783,0.0015411293,0.0005590582,0.012812332,0.0017451887,0.000028488254,0.003990548],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928063,0.00036864847,0.0000463422,0.00013317305,0.00006027832,0.00011092993],"domain_scores_gemma":[0.99889237,0.00026223954,0.0002231015,0.00009516827,0.000085643966,0.00044152237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023363081,0.0017238838,0.0030355933,0.0005351566,0.00056473125,0.0010744935,0.0009323277,0.0022815187,0.0060998974],"category_scores_gemma":[0.0015657329,0.0006445401,0.0011547216,0.00059689773,0.0018251548,0.0011230294,0.00041068858,0.002387993,0.0014162612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9534246,0.023370882,0.0008776269,0.000387609,0.00041113584,0.00005177157,0.000061691164,0.0003416823,0.007954074,0.00012372846,0.0007400791,0.012255143],"study_design_scores_gemma":[0.8158563,0.18200992,0.0009980518,0.00001705871,0.00009131614,0.000026150788,0.00001439278,0.00021155359,0.0004077153,0.000057461413,0.00030303394,0.000007104357],"about_ca_topic_score_codex":0.00054010603,"about_ca_topic_score_gemma":0.00092401175,"teacher_disagreement_score":0.0060998974,"about_ca_system_score_codex":0.0006051098,"about_ca_system_score_gemma":0.0015498807,"threshold_uncertainty_score":0.020406246},"labels":[],"label_agreement":null},{"id":"W2323323362","doi":"10.1089/humc.2014.154","title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","year":2015,"lang":"en","type":"review","venue":"Human Gene Therapy Clinical Development","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Genetic enhancement; Disease; Biology; Phenotype; Gene; Animal model; Gene delivery; Viral vector; Bioinformatics; Recombinant DNA; Computational biology; Cancer research; Medicine; Pathology; Genetics","score_opus":0.22756435923025517,"score_gpt":0.4447940573641431,"score_spread":0.21722969813388796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323323362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022470098,0.997666,0.00033219327,0.0005136222,0.00017571874,0.000004172598,0.000012925211,0.0000080725,0.0010625229],"genre_scores_gemma":[0.0008368356,0.9978078,0.00041779017,0.00026409118,0.000084719424,0.000006833268,0.000024164547,0.0000020288041,0.0005558296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998604,0.000031592186,0.00001747877,0.000019947509,0.00005734414,0.000013167322],"domain_scores_gemma":[0.99972886,0.00015642973,0.000028118508,0.000008818347,0.000051852774,0.000025898895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008459206,0.0004562885,0.00089036714,0.001459337,0.00017832231,0.00069806504,0.0005819646,0.0010661063,0.0021220895],"category_scores_gemma":[0.0005014512,0.00016499338,0.00047791353,0.00082869723,0.0005498721,0.0011626785,0.00041194644,0.0020223102,0.0009085205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009752594,0.00011061174,0.00024105672,0.010350566,0.00006518399,0.0003800635,0.00008194412,0.00040636878,0.00909145,0.009518988,0.02152765,0.94812864],"study_design_scores_gemma":[0.000018581812,0.0001609382,0.00067131297,0.001869839,0.00005916697,0.0017161513,0.000057747056,0.000103385144,0.0014296597,0.0036157956,0.9902795,0.00001797375],"about_ca_topic_score_codex":0.0006037997,"about_ca_topic_score_gemma":0.0012859759,"teacher_disagreement_score":0.0021220895,"about_ca_system_score_codex":0.00044468231,"about_ca_system_score_gemma":0.0006778713,"threshold_uncertainty_score":0.0070991516},"labels":[],"label_agreement":null},{"id":"W2420725116","doi":"10.1089/humc.2016.29012.kod","title":"Sequenom, the U.S. Supreme Court, and Personalized Medicine","year":2016,"lang":"en","type":"editorial","venue":"Human Gene Therapy Clinical Development","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dawson College","funders":"","keywords":"Supreme court; Personalized medicine; Law; Political science; Library science; Computer science; Bioinformatics; Biology","score_opus":0.10686721579517461,"score_gpt":0.42001869138472403,"score_spread":0.3131514755895494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420725116","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057791123,0.034445506,0.00017636151,0.17767248,0.7832074,0.000018303217,0.000074889474,0.000045896042,0.004301368],"genre_scores_gemma":[0.0015689282,0.025885602,0.00029534273,0.13775823,0.81296146,0.00005537351,0.000040747018,0.00004451917,0.021389764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923496,0.0022898687,0.00094631733,0.0006463869,0.003427611,0.00034019828],"domain_scores_gemma":[0.9601819,0.030429728,0.0010712433,0.00092978973,0.005675044,0.0017122698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012888311,0.0022874072,0.0031012474,0.003295458,0.006011819,0.009804469,0.0046582506,0.03340186,0.008367743],"category_scores_gemma":[0.044468656,0.0014005684,0.0024966244,0.0022387463,0.00735927,0.0051965886,0.0019498244,0.03646395,0.0043224464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015924306,0.000005020789,0.000015278676,0.00017561509,0.000011859543,0.00006648791,0.000041318577,0.000022840797,0.000019782508,0.0019435511,0.99358904,0.0040932186],"study_design_scores_gemma":[0.000038801492,0.00001219349,0.00017037071,0.0010767011,0.000048645146,0.00010766204,0.000083125386,0.000107348314,0.00007678734,0.005283822,0.9929737,0.000020950649],"about_ca_topic_score_codex":0.008665395,"about_ca_topic_score_gemma":0.022489227,"teacher_disagreement_score":0.03340186,"about_ca_system_score_codex":0.006139794,"about_ca_system_score_gemma":0.009155821,"threshold_uncertainty_score":0.06816071},"labels":[],"label_agreement":null},{"id":"W2562765584","doi":"10.1089/humc.2016.29019.per","title":"User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found","year":2016,"lang":"en","type":"editorial","venue":"Human Gene Therapy Clinical Development","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation, Science and Economic Development Canada","funders":"","keywords":"Key (lock); User Friendly; Genome editing; Computer science; Gene; Download; World Wide Web; Biology; Genetics; CRISPR; Operating system","score_opus":0.03171068162398359,"score_gpt":0.382900122455972,"score_spread":0.3511894408319884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562765584","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028217746,0.0060178917,0.0003337055,0.05838104,0.93181616,0.000019415924,0.000030588446,0.00012197096,0.003250948],"genre_scores_gemma":[0.0005302804,0.005470468,0.0003595248,0.069230676,0.8766956,0.00003497875,0.000045707253,0.000109196444,0.047523662],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99380565,0.0010435438,0.0005264531,0.0005828538,0.0036371069,0.0004044789],"domain_scores_gemma":[0.9844364,0.0060567795,0.0010682709,0.00049184036,0.005011201,0.0029354696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006713682,0.003359283,0.0024246606,0.0020631235,0.0023025014,0.007702474,0.0035940977,0.020474348,0.026727771],"category_scores_gemma":[0.01812041,0.0014157715,0.0022138583,0.0007562134,0.0028990197,0.004918182,0.0022031404,0.029608596,0.01959761],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014901845,0.0000073390206,0.0000060635593,0.00006660187,0.0000047665103,0.000049130926,0.000004536323,0.000010344132,0.00008378424,0.0002814954,0.9947464,0.0047247447],"study_design_scores_gemma":[0.000027449527,0.000017134576,0.00005765546,0.00009217429,0.0000116428855,0.000121405326,0.000009627937,0.00005816626,0.000098165816,0.0005903344,0.9989047,0.000011438487],"about_ca_topic_score_codex":0.0012424161,"about_ca_topic_score_gemma":0.0046763616,"teacher_disagreement_score":0.026727771,"about_ca_system_score_codex":0.002799264,"about_ca_system_score_gemma":0.003078314,"threshold_uncertainty_score":0.089413285},"labels":[],"label_agreement":null},{"id":"W2789451500","doi":"10.1089/humc.2017.249","title":"A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients","year":2018,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Medicine; Osteoarthritis; Visual analogue scale; Placebo; Knee pain; Clinical trial; Internal medicine; Patella; Adverse effect; Urology; Physical therapy; Surgery; Pathology","score_opus":0.13105684447439805,"score_gpt":0.41690224746679483,"score_spread":0.2858454029923968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789451500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126524,0.0022675595,0.000780429,0.00029893304,0.00026477862,0.003497779,0.00054238056,0.000078864825,0.0010040206],"genre_scores_gemma":[0.9827032,0.001750499,0.002683987,0.0011175736,0.00040741617,0.007440337,0.001086309,0.000021035114,0.002789649],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994438,0.00024994565,0.000040312836,0.000117739655,0.000055071065,0.00009318798],"domain_scores_gemma":[0.9991794,0.0001806199,0.00016862252,0.00007639144,0.00007519549,0.00031973276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017261493,0.0011974467,0.0026893278,0.00037423364,0.0004467787,0.0007255158,0.00062451675,0.0015004162,0.004104657],"category_scores_gemma":[0.001002531,0.00044175755,0.0009912589,0.0004361982,0.0012560897,0.0007307822,0.00026876226,0.0018660093,0.00079008954],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9317166,0.02677858,0.0010535895,0.00043386212,0.00041090717,0.000050349456,0.00005352745,0.0003243446,0.018886259,0.00011162379,0.0006036688,0.019576697],"study_design_scores_gemma":[0.7461592,0.25047377,0.0016831246,0.000014999516,0.00011684393,0.00003240065,0.000014161007,0.00022352804,0.00086018245,0.00005168473,0.00036138803,0.000008746987],"about_ca_topic_score_codex":0.00040906275,"about_ca_topic_score_gemma":0.0009268519,"teacher_disagreement_score":0.004104657,"about_ca_system_score_codex":0.00039028842,"about_ca_system_score_gemma":0.0012994176,"threshold_uncertainty_score":0.01373142},"labels":[],"label_agreement":null},{"id":"W2963380471","doi":"10.1089/humc.2018.201","title":"The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost","year":2019,"lang":"en","type":"review","venue":"Human Gene Therapy Clinical Development","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Authorization; Cell therapy; Medicine; Genetic enhancement; Food and drug administration; Stem-cell therapy; Business; Pharmacology; Cell; Internal medicine; Gene; Biology; Computer science","score_opus":0.20598711153356525,"score_gpt":0.4292700288717852,"score_spread":0.22328291733821998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963380471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27564102,0.6210185,0.0027995578,0.02888333,0.0004874529,0.00043356823,0.018258376,0.000082398146,0.0523957],"genre_scores_gemma":[0.7481221,0.23256886,0.0034716297,0.004936758,0.0010047783,0.00044032806,0.007571019,0.00008009393,0.0018044051],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9853307,0.0042448193,0.0033493473,0.0012565491,0.0053038034,0.0005147444],"domain_scores_gemma":[0.9058293,0.056339584,0.029587416,0.0011345418,0.0056783757,0.0014307403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010184298,0.00027900338,0.00084760616,0.006565767,0.0007646038,0.0040138755,0.0008508316,0.000881515,0.0066533484],"category_scores_gemma":[0.061265144,0.00027732013,0.0012901826,0.015760304,0.0012232413,0.0045243474,0.0010245651,0.0013882713,0.0005953534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017480925,0.0003032681,0.2322537,0.028393893,0.0014591854,0.0017310416,0.0018071873,0.0011464183,0.00092315266,0.024051677,0.049703203,0.6564792],"study_design_scores_gemma":[0.00033833634,0.0009781066,0.53221744,0.03384505,0.0024728535,0.0104306005,0.0082121305,0.0018388713,0.0015644535,0.015175131,0.39268795,0.00023907189],"about_ca_topic_score_codex":0.004518977,"about_ca_topic_score_gemma":0.004926055,"teacher_disagreement_score":0.010184298,"about_ca_system_score_codex":0.0042034113,"about_ca_system_score_gemma":0.0029459244,"threshold_uncertainty_score":0.053860366},"labels":[],"label_agreement":null},{"id":"W4255681473","doi":"10.1089/hum.2014.154","title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","year":2014,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Cystic fibrosis; Genetic enhancement; Medicine; Gene; Biology; Internal medicine; Genetics","score_opus":0.06083135663043778,"score_gpt":0.3244637290561704,"score_spread":0.2636323724257326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255681473","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093397304,0.6423891,0.16946143,0.04993751,0.005941521,0.0010749269,0.0019673766,0.0018305659,0.034000255],"genre_scores_gemma":[0.20475723,0.616227,0.1365251,0.011460141,0.0019341386,0.0018670363,0.0035300911,0.0004384225,0.023260841],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992473,0.00040172267,0.00004952211,0.000078853,0.00015524047,0.00006737325],"domain_scores_gemma":[0.9991208,0.0004313596,0.000121589655,0.00011114936,0.00009402362,0.00012114474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004503488,0.000811806,0.0012946485,0.0010401084,0.00034442998,0.0015222259,0.0010202437,0.002685789,0.0041565164],"category_scores_gemma":[0.0012876568,0.0003040423,0.00082486053,0.00045367223,0.0016262169,0.00228675,0.0007055747,0.0031932434,0.00077332964],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036266625,0.0016096694,0.0034050194,0.004191668,0.0003046335,0.0025504266,0.00053859485,0.0020607875,0.4997848,0.067019984,0.032529227,0.38237852],"study_design_scores_gemma":[0.0012177974,0.016560644,0.008475792,0.0026037656,0.0005898227,0.011928168,0.0006841541,0.0038904252,0.13361943,0.046217285,0.7739884,0.00022426526],"about_ca_topic_score_codex":0.0004858347,"about_ca_topic_score_gemma":0.0008482719,"teacher_disagreement_score":0.004503488,"about_ca_system_score_codex":0.00053349143,"about_ca_system_score_gemma":0.00078660273,"threshold_uncertainty_score":0.023817003},"labels":[],"label_agreement":null}]}